Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent Roche patent reports new agents for obesity

Dec. 16, 2008

New antidiabetic agents disclosed in recent Merck Frosst patent

Dec. 16, 2008

Amylin, Lilly and Alkermes present update on DURATION clinical program for Byetta

Dec. 16, 2008

Xoma provides preclinical animal data for diabetes drug XOMA-052

Dec. 16, 2008

Qnexa meets primary endpoint in 28-week EQUATE study

Dec. 16, 2008

Recent patents disclose new treatments for obesity

Dec. 15, 2008

Recent patents describe new treatment options for endocrine-associated disorders

Dec. 15, 2008

Halozyme starts dosing in phase I trial of bisphosphonate plus rHuPH20 enzyme

Dec. 15, 2008

Futura reports results from phase I study of PET-500 for premature ejaculation

Dec. 15, 2008

Recent Amgen patents describe novel treatments for anemia

Dec. 12, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...